We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$966M
Cap. Flow
+$904M
Cap. Flow %
42.33%
Top 10 Hldgs %
53.7%
Holding
111
New
40
Increased
26
Reduced
11
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 8.02%
2 Consumer Discretionary 6.56%
3 Industrials 4.19%
4 Communication Services 3.91%
5 Healthcare 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPB icon
51
PUT
Campbell Soup
CPB
$6.67B
$8.98M 0.42%
200,000
-350,000
-64% -$15M
OPLN
52
Openlane
OPLN
$4.36B
$8.8M 0.41%
+766,180
New +$8.59M
AROC icon
53
CALL
Archrock
AROC
$6.16B
$8.79M 0.41%
200,200
-169,800
-46% -$6.33M
AROC icon
54
PUT
Archrock
AROC
$6.16B
$8.78M 0.41%
+200,000
New +$7.46M
SPB icon
55
Spectrum Brands
SPB
$2.04B
$8.69M 0.41%
109,000
-231,000
-68% -$17.3M
AHD
56
CALL
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$8.61M 0.4%
200,000
+161,600
+421% +$6.96M
ACAD icon
57
Acadia Pharmaceuticals
ACAD
$4.39B
$8.52M 0.4%
+350,000
New +$8.85M
AHD
58
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$7.63M 0.36%
177,297
+150,152
+553% +$6.46M
VVUS
59
PUT
DELISTED
Vivus Inc
VVUS
$7.29M 0.34%
122,710
+50,210
+69% +$3.57M
STKL
60
DELISTED
SunOpta
STKL
$5.91M 0.28%
+500,000
New +$5.02M
ETFC
61
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$5.88M 0.28%
255,400
-394,600
-61% -$8.64M
MDCO
62
DELISTED
Medicines Co
MDCO
$5.68M 0.27%
+200,000
New +$6.62M
DYAX
63
DELISTED
DYAX CORPORATION
DYAX
$5.39M 0.25%
+600,000
New +$5.46M
NTGR icon
64
PUT
NETGEAR
NTGR
$648M
$5.06M 0.24%
+150,000
New +$5.02M
GEVA
65
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$4.98M 0.23%
+60,000
New +$5.55M
VEEV icon
66
CALL
Veeva Systems
VEEV
$34.4B
$4.94M 0.23%
+185,000
New +$5.99M
HRL icon
67
PUT
Hormel Foods
HRL
$13.9B
$4.93M 0.23%
200,000
+100,000
+100% +$2.3M
PBYI icon
68
Puma Biotechnology
PBYI
$391M
$4.17M 0.2%
+40,000
New +$4.7M
RARE icon
69
Ultragenyx Pharmaceutical
RARE
$2.46B
$3.91M 0.18%
+80,000
New +$4.12M
XLNX
70
DELISTED
Xilinx Inc
XLNX
$3.78M 0.18%
+69,600
New +$3.46M
NPO icon
71
CALL
Enpro
NPO
$7.06B
$3.71M 0.17%
+51,000
New +$3.62M
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.33M 0.16%
+56,000
New +$3.33M
SUNE
73
DELISTED
SUNEDISON, INC COM
SUNE
$2.83M 0.13%
150,000
-650,000
-81% -$10.8M
CMRX
74
DELISTED
Chimerix, Inc.
CMRX
$1.35M 0.06%
+59,209
New +$1.19M
DE icon
75
CALL
Deere & Co
DE
$163B
$926K 0.04%
+10,200
New +$892K

Similar funds

Tourbillon Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Tourbillon Capital Partners held 111 positions worth $2.14B, up 83% from $1.17B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tourbillon Capital Partners deployed $904M of net new capital in Q1 2014, opening 40 new positions and adding to 26 existing holdings. Its largest new stake was Nokia: 3,000,000 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.5% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Archrock, an estimated $22.7M trimmed.

  • Tourbillon Capital Partners's largest Q1 2014 buy was Nokia: 3,000,000 shares worth $22M.
  • Tourbillon Capital Partners added most to DISH Network Corp. in Q1 2014, an estimated $54.9M increase.
  • Tourbillon Capital Partners's biggest Q1 2014 reduction was Archrock, cutting an estimated $22.7M.
  • Tourbillon Capital Partners fully exited Caesars Entertainment Corporation in Q1 2014, selling an estimated $15.2M.
  • Tourbillon Capital Partners's ten largest holdings make up 54% of its $2.14B portfolio in Q1 2014.
  • Tourbillon Capital Partners opened 40 new positions and closed 34 in Q1 2014.
  • Tourbillon Capital Partners's portfolio value rose 83% quarter-over-quarter to $2.14B.

Based on Tourbillon Capital Partners's 13F filing for Q1 2014, filed 15 May 2014.